Alwin G Schuller

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Emergency Department

Epidermal Growth Factor Receptor

Small Cell Lung Cancer

Top Venues

Molecular cancer therapeutics

Science translational medicine

Communications biology

This page only lists publications with an associated author ORCID identifier.

Publications

Rhys D O Jones, Klas Petersson, Areya Tabatabai, Larry Bao, Helen Tomkinson, Alwin G Schuller
Pharmacokinetic/Pharmacodynamic Analysis of Savolitinib Plus Osimertinib in an EGFR-Mutation Positive, MET-Amplified Non-Small Cell Lung Cancer Model. Molecular cancer therapeutics (2023)
Aatman S Doshi, Susan Cantin, Marylens Hernandez, Srimathi Srinivasan, Sharon Tentarelli, Matthew Griffin, Yanjun Wang, Petar Pop-Damkov, Laura B Prickett, Cecilia Kankkonen, Minhui Shen, Maryann San Martin, Song Wu, M Paola Castaldi, Hormas Ghadially, Jeffrey Varnes, Sonya Gales, David Henry, Clare Hoover, Deanna A Mele, Iain Simpson, Eric T Gangl, Scott N Mlynarski, M Raymond V Finlay, Lisa Drew, Stephen E Fawell, Wenlin Shao, Alwin G Schuller
Novel arginase inhibitor, AZD0011, demonstrates immune cell stimulation and anti-tumor efficacy with diverse combination partners. Molecular cancer therapeutics (2023)
Claire M Patterson, Srividya B Balachander, Iain Grant, Petar Pop-Damkov, Brian Kelly, William McCoull, Jeremy S Parker, Michael Giannis, Kathryn J Hill, Francis D Gibbons, Edward J Hennessy, Paul D Kemmitt, Alexander R Harmer, Sonya Gales, Stuart Purbrick, Sean Redmond, Matthew Skinner, Lorraine Graham, J Paul Secrist, Alwin G Schuller, Shenghua Wen, Ammar Adam, Corinne Reimer, Justin Cidado, Martin Wild, Eric Gangl, Stephen E Fawell, Jamal Saeh, Barry R Davies, David J Owen, Marianne B Ashford
Design and optimisation of dendrimer-conjugated Bcl-2/xL inhibitor, AZD0466, with improved therapeutic index for cancer therapy. Communications biology 4 (1) (2021)
Pınar Özden Eser, Raymond M Paranal, Jieun Son, Elena Ivanova, Yanan Kuang, Heidi M Haikala, Ciric To, Jeffrey J Okoro, Kshiti H Dholakia, Jihyun Choi, Yoonji Eum, Atsuko Ogino, Pavlos Missios, Dalia Ercan, Man Xu, Michael J Poitras, Stephen Wang, Kenneth H Ngo, Michael Dills, Masahiko Yanagita, Timothy Lopez, Mika Lin, Jeanelle Tsai, Nicolas Floch, Emily S Chambers, Jennifer Heng, Rana Anjum, Alison D Santucci, Kesi S Michael, Alwin G Schuller, Darren Ae Cross, Paul D Smith, Geoffrey R Oxnard, David A Barbie, Lynette M Sholl, Magda Bahcall, Sangeetha Palakurthi, Prafulla C Gokhale, Cloud P Paweletz, George Q Daley, Pasi A Janne
Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR-mutant lung cancer. Science translational medicine 13 (609) (2021)